information he had obtained by virtue of his positions to sell SLC shares and for imparting a false statement with the intention to mislead any person concerning facts sensitive to the SLC share price
Mr. Wittawat Pornkul Mr. Wittawat Pornkul as the Chief Executive Officer, Managing Director and Director of Dcon Product Public Company Limited ("DCON"), knew or possessed an inside
\(Microsoft Word - 16 \\312\\244 61_Eng_.doc\) August 16th, 2018 To : Managing Director The Stock Exchange of Thailand Re : The acquisition of investment in Muengloei-Ram Co.,Ltd.(s remainder and new
managing director shall be the authorized person to act on behalf of the Company to negotiate, enter into an agreement, execute a share sale and purchase agreement, including other relevant agreements and
Microsoft Word - letYQ118MD&AE .doc ( Translation ) 14th May 2018 Subject: Management Discussion and Analysis (MD&A) for the 1st quarter period of year 2018 To: Managing Director of the Stock
AC 52/07-003 ACC1/19-056 11 November 2019 Subject : The Purchase of the Ordinary Shares of Duwell Intertrade Co., Ltd. To: Director and Managing Director The Stock Exchange of Thailand Qualitech
and interest Objectives To be used for working capital (4) Nature of relationship The Company holds 70% of the share in the Company’s subsidiary, KT Medical Service Company Limited and the details of
pipe. Currently the Company holds portion of 25% of paid-up capital. After the waiving, the Company's portion of holding share will reduce from 25.00% to 15.15% of paid-up capital. This transaction is
due primarily to its market share increase in Malaysia, Vietnam and Cambodia, notwithstanding the products delivery postponement from some project delays in Myanmar and Vietnam to early 2019. Profit for